Dare Bioscience (DARE) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Dare Bioscience Received Payment of $2.5M Under Grant Agreement
TipRanksDec 4 08:12 ET
Press Release: Daré Bioscience Announces $2.5 Million Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1
Dow JonesDec 4 08:00 ET
Maxim Group Maintains Dare Bioscience(DARE.US) With Hold Rating
Moomoo NewsNov 16 10:32 ET · Ratings
Dare Bioscience Files to Sell 2.75M Shares of Common Stock for Holders
TipRanksNov 15 17:20 ET
Q3 2024 Dare Bioscience Inc Earnings Call
Yahoo FinanceNov 15 13:54 ET
Dare Bioscience Analyst Ratings
BenzingaNov 15 07:08 ET · Ratings

Comments

Trytosaveabit

Nov 13 07:04

News

$Dare Bioscience (DARE.US)$ Reuters
3 mins ago
Daré Bioscience Announces Grant to Support Development of a Novel Non-Hormonal Contraceptive Candidate and Expansion of Ovaprene® Pivotal Study Clinical Trial Sites

1

Jaguar8

Nov 13 07:00

NEWS

$Dare Bioscience (DARE.US)$
Daré Bioscience Announces Grant to Support Development of a Novel Non-Hormonal Contraceptive Candidate and Expansion of Ovaprene® Pivotal Study Clinical Trial Sites
Daré Bioscience (NASDAQ: DARE) has secured a grant of up to $10.7 million from the Bill & Melinda Gates Foundation. The funding will support two key initiatives: the development of a novel non-hormonal intravaginal contraceptive product candidate and the expansion of clinical sites for the ongoing Ovapr...

Jaguar8

Oct 23 21:59

Put on watch. $10M award. News came after market opened/mid day. Didn’t run. Low float

$Dare Bioscience (DARE.US)$

1

2

Trytosaveabit

Oct 23 11:50

New 8K filed in last 15 minutes

$Dare Bioscience (DARE.US)$ Daré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health

DARE-HPV is a potential first-in-category treatment for human papillomavirus (HPV)-related cervical disease which could change the treatment paradigm for clinical HPV management.

Essentially all cervical cancer cases worldwide are caused by HPV infection.

SAN DIEGO, October 23, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE),...

Stock_Drift

Oct 23 11:49

$Dare Bioscience (DARE.US)$

1

DARE Dare Bioscience

Trade Overview

Capital Trend

News

Comments